Stock Financial Ratios, Dividends, Split History

AFSI / AmTrust Financial Services, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price14.56
Volume1,323,900.00
Market Cap ($M)2,415.92
Enterprise Value ($M)3,119.93
Book Value ($M)3,757.00
Book Value / Share19.13
Price / Book0.76
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Weighted Average Number Diluted Shares Outstanding Adjustment 0
Weighted Average Number Of Diluted Shares Outstanding 185,961,000
Common Stock Shares Outstanding 196,053,000
Weighted Average Number Of Shares Outstanding Basic 185,961,000
Common Shares Outstanding 196,256,697
Scoring Models
Piotroski F-Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.07
Return on Assets (ROA)-0.01
Return on Equity (ROE)-0.10
Balance Sheet (mrq) ($M)
Assets25,701.00
Liabilities21,768.60
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Revenues5,958,941,000.00
Other Premium Revenue Net0.00
Revenue Other Financial Services0.00
Operating Income-453.87
Net Income-334.88
Earnings Per Share Diluted-2.23
Earnings Per Share Basic-2.23
Cash Flow Statement (mra) ($M)
Cash From Operations-375.30
Cash from Investing633.71
Cash from Financing633.71
Identifiers and Descriptors
CUSIP032359309
Central Index Key (CIK)1365555
Related CUSIPS
003235930 032359909 032359959 323593095

Split History

Stock splits are used by AmTrust Financial Services, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

AmTrust Shares Rise After Evergreen Parent Sweetens Bid

2018-06-08 zacks
Shares of AmTrust Financial Services, Inc. (AFSI - Free Report) gained 3.3% in the last trading session after the acquisition offer price was raised 9.3% or $1.25 per share. Evergreen Parent will buy 45% of the company’s stake, which Karfunkel-Zyskind Family does not own at present for a new purchase consideration of $14.75. The deal is valued at $2.95 billion and is estimated to culminate in the second half of 2018, subject to closing conditions The new offer represents 45% premium to the closing price on Jan 9, 2018. (47-0)

Deals of the day-Mergers and acquisitions

2018-06-07 reuters
June 7 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1410 GMT on Thursday: ** Japan’s Fujifilm Holdings Corp said it may have no choice but to abandon a $6.1 billion merger with Xerox Corp if there is no progress in talks with the U.S. firm’s new board for about half a year. ** U.S. insurer AmTrust Financial Services Inc agreed to be acquired by a group of investors for a sweetened $2. (110-0)

Deals of the day-Mergers and acquisitions

2018-06-07 reuters
June 7 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1200 GMT on Thursday: ** Japan’s Fujifilm Holdings Corp said it may have no choice but to abandon a $6.1 billion merger with Xerox Corp if there is no progress in talks with the U.S. firm’s new board for about half a year. ** U.S. insurer AmTrust Financial Services Inc agreed to be acquired by a group of investors for a sweetened deal value of $2. (104-1)

Evergreen Parent raises AmTrust buy-out deal value to $2.95 bln

2018-06-07 reuters
(Reuters) - U.S. insurer AmTrust Financial Services Inc (AFSI.O) agreed to be bought by a group of investors for $2.95 billion, up from an earlier offer of $2.7 billion. (23-0)

Stocks To Watch: Eyes On Apple's WWDC, SCOTUS And D.C.

2018-06-02 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (932-4)

CUSIP: 032359309